Total Payments
$2,533
2024 Payments
$26.13
Companies
16
Transactions
40
Medicare Patients
5,403
Medicare Billing
$445,305
Payment Breakdown by Category
Consulting$1,750 (69.1%)
Food & Beverage$783.49 (30.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1,750 | 1 | 69.1% |
| Food and Beverage | $783.49 | 39 | 30.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $1,829 | 2 | $0 (2017) |
| AbbVie Inc. | $199.56 | 15 | $0 (2023) |
| Sun Pharmaceutical Industries Inc. | $107.60 | 4 | $0 (2023) |
| GENZYME CORPORATION | $51.95 | 2 | $0 (2023) |
| Lilly USA, LLC | $48.94 | 3 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $45.22 | 1 | $0 (2019) |
| PFIZER INC. | $44.82 | 2 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $44.05 | 2 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $30.07 | 2 | $0 (2022) |
| Janssen Biotech, Inc. | $26.13 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $26.13 | 1 | Janssen Biotech, Inc. ($26.13) |
| 2023 | $228.31 | 10 | Sun Pharmaceutical Industries Inc. ($85.11) |
| 2022 | $350.77 | 23 | ABBVIE INC. ($127.92) |
| 2020 | $53.66 | 3 | AbbVie Inc. ($53.66) |
| 2019 | $45.22 | 1 | Novartis Pharmaceuticals Corporation ($45.22) |
| 2017 | $1,829 | 2 | Allergan Inc. ($1,829) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: Immunology | ||||||
| 11/02/2023 | Fresenius Kabi USA, LLC | IDACIO (Biological) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Biosimilars | ||||||
| 07/28/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Immunology | ||||||
| 06/06/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: IMMUNOLOGY | ||||||
| 05/17/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: Immunology | ||||||
| 05/10/2023 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological), Winlevi | Food and Beverage | Cash or cash equivalent | $30.30 | General |
| Category: Dermatology | ||||||
| 04/11/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $39.04 | General |
| Category: Immunology | ||||||
| 03/30/2023 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $38.81 | General |
| Category: Dermatology | ||||||
| 03/09/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: DERMATOLOGY | ||||||
| 03/01/2023 | Sun Pharmaceutical Industries Inc. | BLU-U (Medical Supply), Odomzo | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Dermatology | ||||||
| 02/09/2023 | Arcutis Biotherapeutics, Inc. | — | Food and Beverage | In-kind items and services | $15.44 | General |
| 12/02/2022 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: DERMATOLOGY | ||||||
| 12/01/2022 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: Immunology | ||||||
| 11/22/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.82 | General |
| Category: IMMUNOLOGY | ||||||
| 11/17/2022 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: Dermatology | ||||||
| 11/10/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2022 | ABBVIE INC. | SKYRIZI (Biological), HUMIRA | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: IMMUNOLOGY | ||||||
| 11/03/2022 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $15.47 | General |
| Category: Dermatology | ||||||
| 10/12/2022 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $16.32 | General |
| Category: Immunology | ||||||
| 10/06/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/08/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.72 | General |
| Category: IMMUNOLOGY | ||||||
| 08/18/2022 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $13.75 | General |
| 07/27/2022 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: DERMATOLOGY | ||||||
| 07/18/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: IMMUNOLOGY | ||||||
| 07/14/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.26 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 819 | 1,168 | $214,330 | $51,616 |
| 2022 | 16 | 1,493 | 2,702 | $501,896 | $123,089 |
| 2021 | 19 | 1,213 | 1,833 | $167,558 | $100,104 |
| 2020 | 25 | 1,878 | 3,224 | $337,999 | $170,496 |
Total Patients
5,403
Total Services
8,927
Medicare Billing
$445,305
Procedure Codes
68
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 300 | 337 | $79,195 | $19,090 | 24.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 102 | 111 | $30,858 | $8,542 | 27.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 143 | 154 | $33,572 | $6,379 | 19.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 93 | 101 | $30,300 | $6,319 | 20.9% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 37 | 47 | $22,090 | $6,073 | 27.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 103 | 365 | $6,935 | $1,847 | 26.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 30 | 42 | $5,880 | $1,758 | 29.9% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 11 | 11 | $5,500 | $1,608 | 29.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 406 | 539 | $126,665 | $31,557 | 24.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 166 | 192 | $53,376 | $16,741 | 31.4% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 61 | 139 | $65,330 | $14,390 | 22.0% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 184 | 445 | $66,350 | $13,998 | 21.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 215 | 260 | $56,680 | $11,059 | 19.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 126 | 145 | $43,500 | $9,623 | 22.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 169 | 788 | $14,972 | $4,228 | 28.2% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2022 | 17 | 25 | $11,900 | $3,662 | 30.8% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2022 | 13 | 14 | $11,102 | $3,504 | 31.6% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 13 | 14 | $11,452 | $3,449 | 30.1% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 26 | 30 | $9,000 | $2,587 | 28.7% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2022 | 15 | 18 | $9,000 | $2,200 | 24.4% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2022 | 17 | 22 | $8,514 | $1,875 | 22.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 34 | 39 | $4,500 | $1,617 | 35.9% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2022 | 12 | 13 | $4,235 | $1,432 | 33.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 19 | 19 | $5,320 | $1,167 | 21.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 340 | 387 | $39,702 | $21,494 | 54.1% |
About Dr. Bert Tavelli, MD
Dr. Bert Tavelli, MD is a Dermatology healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1013918978.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bert Tavelli, MD has received a total of $2,533 in payments from pharmaceutical and medical device companies, with $26.13 received in 2024. These payments were reported across 40 transactions from 16 companies. The most common payment nature is "Consulting Fee" ($1,750).
As a Medicare-enrolled provider, Tavelli has provided services to 5,403 Medicare beneficiaries, totaling 8,927 services with total Medicare billing of $445,305. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Portland, OR
- Active Since 08/02/2005
- Last Updated 03/07/2023
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1013918978
Products in Payments
- SKYRIZI (Biological) $148.51
- DUPIXENT (Biological) $96.00
- ILUMYA (Biological) $91.60
- RINVOQ (Biological) $51.05
- TALTZ (Drug) $48.94
- COSENTYX (Biological) $45.22
- EUCRISA (Drug) $44.82
- TREMFYA (Drug) $26.13
- SPEVIGO (Drug) $24.65
- IDACIO (Biological) $19.22
- VTAMA (Drug) $17.96
- Sotyktu (Drug) $16.32
- BLU-U (Medical Supply) $16.00
- OPZELURA (Drug) $15.47
- Cimzia (Drug) $13.01
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Portland
Andrew Blauvelt, Md, MD
Dermatology — Payments: $2.6M
Dermatology $2.6M
Eric Simpson, Md, MD
Dermatology — Payments: $2.2M
Dermatology $2.2M
Benjamin Ehst, M.d., Ph.d, M.D., PH.D
Dermatology — Payments: $1.5M
Dermatology $1.5M
Dr. Jason Hawkes, Md, Ms, MD, MS
Dermatology — Payments: $876,779
Dermatology $876,779
Dr. Omar Qutub, Md, MD
Dermatology — Payments: $73,858
Dermatology $73,858
Alex Ortega Loayza, Md, MD
Dermatology — Payments: $72,824
Dermatology $72,824